ESTHER HWANG: Open Payments
NPI 1851696595 · CHINO HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 28 payments from 16 companies in 2025. Trend: 2023 $2,538 · 2024 $1,231 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $140 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| UCB, Inc. | 2 | $60 |
| Teleflex LLC | 2 | $48 |
| Amgen Inc. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $43 |
| LEO Pharma Inc. | 2 | $38 |
| Lilly USA, LLC | 1 | $29 |
| Incyte Corporation | 1 | $25 |
Products named: DUPIXENT, COSENTYX, Bimzelx, ARROW, Otezla, Zoryve, ADBRY, TALTZ.
Industry payments across CA — which companies pay providers there.
